Ariana Centa-rekin lankidetzan egindako argitalpenak (3)

2021

  1. Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2019

  1. Paclitaxel-trastuzumab mixed nanovehicle to target HER2-overexpressing tumors

    Nanomaterials, Vol. 9, Núm. 7

2018

  1. The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation

    Molecular Oncology, Vol. 12, Núm. 7, pp. 1061-1076